Latest news with #AnalyticalBioventuresS.C.A.
Yahoo
3 days ago
- Business
- Yahoo
Eurofins Scientific SE: Director/PDMR Shareholding
LUXEMBOURG, June 10, 2025--(BUSINESS WIRE)--Eurofins Scientific SE ( has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM 1. Details of the person discharging managerial responsibilities/person closely associated a) Name Analytical Bioventures S.C.A (RCS B89265)23, Va Fleuri, L-1526 Luxembourg 2. Reason for the notification a) Position / status Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin b) Initial notification / amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E. b) LEI 529900JEHFM47DYY3S57 4. Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument Share Identification code ISIN: FR0014000MR3 b) Nature of the transaction Acquisition of shares c) Price(s) and volume(s) Price(s) Volume(s) EUR 57.091200 2000 d) Aggregated information — Aggregated volume 2000 — Price EUR 114,182.40 e) Date of the transaction 2025-06-05 f) Place of the transaction XPAR NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM 1. Details of the person discharging managerial responsibilities/person closely associated a) Name Analytical Bioventures S.C.A (RCS B89265)23, Va Fleuri, L-1526 Luxembourg 2. Reason for the notification a) Position / status Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin b) Initial notification / amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E. b) LEI 529900JEHFM47DYY3S57 4. Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument Share Identification code ISIN: FR0014000MR3 b) Nature of the transaction Acquisition of shares c) Price(s) and volume(s) Price(s) Volume(s) EUR 57.375900 2000 d) Aggregated information — Aggregated volume 2000 — Price EUR 114,751.80 e) Date of the transaction 2025-06-06 f) Place of the transaction XPAR NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM 1. Details of the person discharging managerial responsibilities/person closely associated a) Name Analytical Bioventures S.C.A (RCS B89265)23, Va Fleuri, L-1526 Luxembourg 2. Reason for the notification a) Position / status Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin b) Initial notification / amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E. b) LEI 529900JEHFM47DYY3S57 4. Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument Share Identification code ISIN: FR0014000MR3 b) Nature of the transaction Acquisition of shares c) Price(s) and volume(s) Price(s) Volume(s) EUR 58.358800 2000 d) Aggregated information — Aggregated volume 2000 — Price EUR 116,117.60 e) Date of the transaction 2025-06-09 f) Place of the transaction XPAR For more information, please visit About Eurofins – the global leader in bio-analysis Eurofins is Testing for Life. With ca. 63,000 staff across a network of more than 950 laboratories in over 1,000 companies in 60 countries, Eurofins offers a portfolio of over 200,000 analytical methods. Eurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange. View source version on Contacts Investor RelationsEurofins Scientific SEPhone: +32 2 766 1620E-mail: ir@ Sign in to access your portfolio
Yahoo
15-05-2025
- Business
- Yahoo
Eurofins Scientific SE: Director/PDMR Shareholding
LUXEMBOURG, May 15, 2025--(BUSINESS WIRE)--Eurofins Scientific SE ( (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM 1. Details of the person discharging managerial responsibilities/person closely associated a) Name Analytical Bioventures S.C.A (RCS B89265)23, Va Fleuri, L-1526 Luxembourg 2. Reason for the notification a) Position / status Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin b) Initial notification / amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E. b) LEI 529900JEHFM47DYY3S57 4. Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument Share Identification code ISIN: FR0014000MR3 b) Nature of the transaction Acquisition of shares c) Price(s) and volume(s) Price(s) Volume(s) EUR 56.034800 2000 d) Aggregated information — Aggregated volume 2000 — Price EUR 112,069.60 e) Date of the transaction 2025-05-13 f) Place of the transaction XPAR NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM 1. Details of the person discharging managerial responsibilities/person closely associated a) Name Analytical Bioventures S.C.A (RCS B89265)23, Va Fleuri, L-1526 Luxembourg 2. Reason for the notification a) Position / status Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin b) Initial notification / amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E. b) LEI 529900JEHFM47DYY3S57 4. Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument Share Identification code ISIN: FR0014000MR3 b) Nature of the transaction Acquisition of shares c) Price(s) and volume(s) Price(s) Volume(s) EUR 54.564900 4000 d) Aggregated information — Aggregated volume 4000 — Price EUR 218,259.60 e) Date of the transaction 2025-05-14 f) Place of the transaction XPAR About Eurofins – the global leader in bio-analysis Eurofins is Testing for Life. With ca. 63,000 staff across a network of more than 950 laboratories in over 1,000 companies in 60 countries, Eurofins offers a portfolio of over 200,000 analytical Scientific S.E. shares are listed on Euronext Paris Stock Exchange. View source version on Contacts For more information, please visit or contact: Investor RelationsEurofins Scientific SEPhone: +32 2 766 1620E-mail: ir@
Yahoo
13-05-2025
- Business
- Yahoo
Eurofins Scientific: Director/PDMR Shareholding
LUXEMBOURG, May 13, 2025--(BUSINESS WIRE)--Eurofins Scientific SE ( has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM 1. Details of the person discharging managerial responsibilities/person closely associated a) Name Analytical Bioventures S.C.A (RCS B89265)23, Va Fleuri, L-1526 Luxembourg 2. Reason for the notification a) Position / status Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin b) Initial notification / amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E. b) LEI 529900JEHFM47DYY3S57 4. Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument Share Identification code ISIN: FR0014000MR3 b) Nature of the transaction Acquisition of shares c) Price(s) and volume(s) Price(s) Volume(s) EUR 56.514200 2000 d) Aggregated information — Aggregated volume 2000 — Price EUR 113,028.40 e) Date of the transaction 2025-05-09 f) Place of the transaction XPAR NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM 1. Details of the person discharging managerial responsibilities/person closely associated a) Name Analytical Bioventures S.C.A (RCS B89265)23, Va Fleuri, L-1526 Luxembourg 2. Reason for the notification a) Position / status Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin b) Initial notification / amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E. b) LEI 529900JEHFM47DYY3S57 4. Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument Share Identification code ISIN: FR0014000MR3 b) Nature of the transaction Acquisition of shares c) Price(s) and volume(s) Price(s) Volume(s) EUR 55.792600 2000 d) Aggregated information — Aggregated volume 2000 — Price EUR 111,585.20 e) Date of the transaction 2025-05-12 f) Place of the transaction XPAR For more information, please visit About Eurofins – the global leader in bio-analysis Eurofins is Testing for Life. With ca. 63,000 staff across a network of more than 950 laboratories in over 1,000 companies in 60 countries, Eurofins offers a portfolio of over 200,000 analytical methods. Eurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange. View source version on Contacts Investor RelationsEurofins Scientific SEPhone: +32 2 766 1620E-mail: ir@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
